Skip to content

Clinical trials

Completed Fallopian Tube Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Completed Country / region: Canada Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20031
20041
20052
20063
20071
20091
20103
20114
20121
20132
20141
20151
20163
20172
20181
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
pharmaand GmbH5
NCIC Clinical Trials Group3
University Health Network, Toronto3
ImmunoGen, Inc.2
ImmunoVaccine Technologies, Inc. (IMV Inc.)2
Novartis Pharmaceuticals2
AbbVie1
Alliance for Clinical Trials in Oncology1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms40
Ovarian Neoplasms32
Carcinoma, Ovarian Epithelial22
Neoplasms5
Peritoneal Neoplasms5
Recurrence5
Endometrial Neoplasms3
Breast Neoplasms2
Neoplasm Metastasis2
Prostatic Neoplasms2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.